|
DRG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08539999713153E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.04670000234242E-08 |
| Normal-vs-Stage2 |
3.350400E-02 |
| Normal-vs-Stage3 |
1.207940E-02 |
| Normal-vs-Stage4 |
1.287650E-02 |
| Stage1-vs-Stage2 |
4.650000E-01 |
| Stage1-vs-Stage3 |
4.542800E-01 |
| Stage1-vs-Stage4 |
4.922400E-01 |
| Stage2-vs-Stage3 |
9.603600E-01 |
| Stage2-vs-Stage4 |
3.767200E-01 |
| Stage3-vs-Stage4 |
3.767800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99570000525284E-08 |
| Normal-vs-AfricanAmerican |
2.13779999999053E-05 |
| Normal-vs-Asian |
6.075800E-02 |
| Caucasian-vs-AfricanAmerican |
5.028800E-01 |
| Caucasian-vs-Asian |
5.312200E-01 |
| AfricanAmerican-vs-Asian |
3.645200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.26870003181301E-09 |
| Normal-vs-Female |
2.225800E-04 |
| Male-vs-Female |
1.024240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.57780999999746E-05 |
| Normal-vs-Extreme_Weight |
6.49079999748281E-08 |
| Normal-vs-Obese |
7.024600E-04 |
| Normal-vs-Extreme_Obese |
2.589800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.580400E-01 |
| Normal_Weight-vs-Obese |
3.001000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.216800E-01 |
| Extreme_Weight-vs-Obese |
1.558030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.708200E-01 |
| Obese-vs-Extreme_Obese |
3.108800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.395700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.62660000005521E-06 |
| Normal-vs-Age(61-80Yrs) |
2.04040000451045E-08 |
| Normal-vs-Age(81-100Yrs) |
9.06140000034306E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.643400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.893600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.622500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.134600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.327900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.454790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.12589999989865E-07 |
| Normal-VS-Type2 PRCC |
4.8634000000547E-06 |
| Normal-VS-KIRP CIMP |
7.249700E-04 |
| Normal-VS-Unclassified PRCC |
1.26119999999119E-07 |
| Type1 PRCC-VS-Type2 PRCC |
4.649200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.456600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.649210E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.018400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.049000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.570000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.187400E-04 |
| Normal-vs-N1 |
8.4057999999998E-05 |
| Normal-vs-N2 |
2.335600E-01 |
| N0-vs-N1 |
8.023600E-01 |
| N0-vs-N2 |
6.509200E-01 |
| N1-vs-N2 |
6.786800E-01 |
|
|
